Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?

Filipa A. Costa, Claire Scullin, Ghaith Al-Taani, Ahmed F. Hawwa, Claire Anderson, Zinaida Bezverhni, Zahida Binakaj, Maria Cordina, Veerle Foulon, Borja Garcia de Bikuña, Han de Gier, Anne Gerd Granås, Olga Grinstova, Nina Griese-Mammen, Jonas Grinceviciene, Svitrigaile Grinceviciene, Susanne Kaae, Loreta Kubiliene, Eduardo L. Mariño, Silvia MartinsPilar Modamio, Giancarlo Nadin, Lotte Stig Nørgaard, Emina Obarcanin, Ivana Tadic, Ljiljana Tasic, James C. Mcelnay*, Kurt E. Hersberger, Tommy Westerlund

*Corresponding author for this work

Research output: Contribution to journalArticle

287 Downloads (Pure)

Abstract

Rationale, Aims, and Objectives: Pharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe.

Method: A cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006.

Results: The provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n = 8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education.

Conclusions: The present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.
Original languageEnglish
JournalJournal of Evaluation in Clinical Practice
Early online date01 Aug 2017
DOIs
Publication statusEarly online date - 01 Aug 2017

Keywords

  • Europe
  • Implementation
  • Medication review
  • Medicines use
  • Pharmaceutical care
  • Pharmacy services

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?'. Together they form a unique fingerprint.

Cite this